Timothy F. Stanton
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, Amino Acid Enzymes and Metabolism, RNA modifications and cancer, Adenosine and Purinergic Signaling
Most-Cited Works
- → Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer(2014)1,045 cited
- → Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)(2009)271 cited
- → Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs(2008)237 cited
- → DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids(2004)17 cited
- → Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity(2022)12 cited
- → Abstract 4134: Reversal of adenosine-mediated immune suppression by CB-708, an orally bioavailable and potent small molecule inhibitor of CD73(2019)3 cited
- Evaluation of the Antimicrobial Activity of Natural Animal Proteins/Peptides In Vitro(2001)
- → Supplementary Figure 4 from Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer(2023)
- → Supplementary Materials and Methods from Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer(2023)
- → Supplementary Figure 6 from Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer(2023)